EMN01
A phase 3, intergroup multicentre, randomized, controlled 3 arm parallel group study to determine the efficacy and safety of lenalidomide in combination with dexamethasone (rd) versus melphalan, prednisone and lenalidomide (mpr) versus cyclophosphamide, prednisone and lenalidomide (cpr) in newly diagnosed multiple myeloma elderly subjects